-
Symbol
-
KYTX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.00001 per share
-
Latest Disclosed Shares Owned
-
3,110,000 shares
-
Security Ownership %
-
5.4%
Bain Capital Life Sciences Opportunities III, LP ownership in Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX)
17 Feb 2026 - Bain Capital Life Sciences Opportunities III, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,110,000 shares of Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX).
This represents 5.4% ownership of the company.
This is the first filing by Bain Capital Life Sciences Opportunities III, LP disclosing ownership of Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX).